Treatment & Research In Psychedelics

Choosing Our Center

Treatment & Research In Psychedelics^SM (TRIP^SM) at Pacific Neuroscience Institute® (PNI®) has two paths that are available to patients. We serve all California communities.

1. Treatment with Ketamine | 310-582-7612
2. Psychedelic-Assisted Clinical Trials | 310-582-7611

Introduction

Mental health issues are a leading cause of disability, and they remain inadequately treated worldwide.

The modest effectiveness of existing treatments such as antidepressants and traditional psychotherapy approaches show us that there is an urgent need for more effective treatments for conditions such as depression, alcoholism, smoking cessation, and end of life suffering.

Early studies of psychedelic-assisted therapies for these conditions have demonstrated much larger and durable effects compared to existing therapies suggesting that there is great potential for psychedelic-assisted treatments to revolutionize the treatment of mental health and behavioral disorders.

Vision & Mission

VISION: Pacific Treatment & Research In Psychedelics (TRIP) is dedicated to the development of psychedelic-assisted therapies and the scientific exploration of how psychedelic medicines and expanded states of consciousness can be harnessed to change behavior, improve brain health and optimize quality of life.

Mission:

• Develop safe and effective psychedelic-assisted therapies for behavioral health conditions including anxiety, depression, addiction, PTSD, grief and related disorders.
• Advance psychedelic science and our understanding of the neuroplastogenic potential of psychedelic medicines for treating mental health disorders, brain injury, neurodegenerative conditions and pain syndromes.
• Help expand access to those in need of psychedelic-assisted therapies including underserved and under-represented communities.
• Educate the medical community and public-at-large on the potential impact of psychedelic-assisted therapies and the growing field of psychedelic science.

TRIP Experience at PNI

Each patient experiences the compassionate expert care from our experienced and highly trained team of TRIP specialists.

• Highly trained and experienced addiction medicine doctor & team of psychedelic guides and mental health experts
• Supportive multidisciplinary care
• Curated personalized patient experience 
• Safe and holistic approach 

TRIP Distinctions

Since 2019, TRIP has achieved numerous achievements and distinctions.

• The only psychedelic clinical trials program in the Providence health system across 51 hospitals and over 1000 clinics in 7 states and the only Providence mental health clinic offering ketamine-assisted psychotherapy.
• One of only a few programs (academic or private practice) conducting psychedelic clinical trials in the western U.S. 
• One of only a few programs in the western U.S. working with multiple psychedelic medicines in clinical trials including psilocybin, LSD, and soon 5Meo-DMT & MDMA.
• One of the highest-enrolling psychedelic clinical trial units in the western US.
• A broad and experienced multidisciplinary clinical trials team of clinician neuroscientists and behavioral healthcare providers including Dr. Keith Heinzerling, Addiction Medicine; Dr. Akansksha Sharma, Neuro-oncology; Dr. Shanthi Gowrinathan, Psychiatry; Karina Sergi, LMFT; Micah Linton, Psychology; Dr. Daniel Kelly, Neurosurgery.

Clinic Location

1301 20^th St #540, Santa Monica, CA 90404 (Map)

Treatment with Ketamine | 310-582-7612
Psychedelic-Assisted Clinical Trials | 310-582-7611

---

Videos about Psychedelic-Assisted Therapy

Treatment & Research In Psychedelics (TRIP) at Pacific Neuroscience Institute | Explainer At PNI’s Treatment & Research In Psychedelics (TRIP) Program, we conduct clinical trails at the forefront of innovative and transformative medicine. TRIP, spearheaded by Daniel Kelly, MD and Keith Heinzerling,… Psychedelic-Assisted Therapy at Pacific Neuroscience Institute Dr. Keith Heinzerling is an addiction medicine specialist and Director of Treatment & Research In Psychedelics (TRIP) at Pacific Neuroscience Institute in Santa Monica, CA. Learn about how psychedelic-assisted therapy… 39. A Life-Changing Clinical Trial with Psychedelics | Vikki’s Grateful Patient Story Vikki was walking her dog and listening to NPR in Santa Monica one day, when she heard an advertisement for an unusual medical trial. Pacific Neuroscience Institute was studying whether… Psychedelic-Assisted Therapy with Ketamine at PNI Using ketamine in a psychedelic-assisted approach, we treat people 16 years and older who are treatment-resistant or who wish to effectively tackle deep-rooted, unresolved trauma that has not been adequately… Think Neuro Podcast: The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg Addiction and depression are two of the most widespread conditions in all of medicine. After decades of research, doctors are still looking for alternatives for when medication and cognitive training… Healing with Visual Art, Music & Mushrooms with Louie Schwartzberg (ft. Deepak Chopra & Dr. Dan Kelly) https://fungiglobalsummit.com/ Voices from the Underground is The Deep Dive, Intimate Conversations with Thought Leaders & Fungi Experts hosted by Louie Schwartzberg. Get Premium Access and join Louie as he digs… Helping Patients and Advancing Science With a Psilocybin Trial | Karina Sergi, MS, MFT Brain Injuries and Psychedelics Ian McCall is a former professional MMA fighter who suffered from symptoms of traumatic brain injuries. After retirement, McCall experienced confusion, anger issues, depression, and suicidal ideation. Feeling hopeless, he… Meet Dr. Heinzerling Dr. Heinzerling is the Director, Pacific Treatment & Research In Psychedelics Program; Internal Medicine – Addiction Medicine, Brain Health Center. He practices internal medicine and is an addiction medicine specialist… Psychedelics Renaissance | Dr. Daniel Kelly Dr. Dan Kelly is the director and one of the four co founders of the Pacific Neuroscience Institute, a multispecialty group of over 35 physicians working across nine centers of… Psychedelic-Assisted Therapy: A New Dawn for Mental Health | Daniel Kelly, MD Adapted from lecture at Claremont McKenna College Thu, September 16, 2021 Alum, Daniel Kelly, M.D. ’82, a neurosurgeon and neuroscientist, discusses the history, current state and future opportunities of psychedelic-assisted… NBC News Features Treatment & Research In Psychedelics (TRIP) at PNI NBC News features Pacific Neuroscience Institute’s Dr. Daniel Kelly & Dr. Keith Heinzerling, and filmmaker Louie Schwartzberg, and PNI’s groundbreaking psychedelic-assisted clinical trial for alcohol use disorder which launched in…

Treatment & Research In Psychedelics (TRIP) at Pacific Neuroscience Institute | Explainer

Psychedelic-Assisted Therapy at Pacific Neuroscience Institute

39. A Life-Changing Clinical Trial with Psychedelics | Vikki’s Grateful Patient Story

Psychedelic-Assisted Therapy with Ketamine at PNI

The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg

Healing with Visual Art, Music & Mushrooms with Louie Schwartzberg (ft. Deepak Chopra & Dr. Dan Kelly) | Fungi Global Summit

Helping Patients and Advancing Science With a Psilocybin Trial | Karina Sergi, MS, MFT

Brain Injuries and Psychedelics

Meet Dr. Heinzerling

Psychedelics Renaissance | Dr. Daniel Kelly

Psychedelic-Assisted Therapy: A New Dawn for Mental Health | Daniel Kelly, MD

NBC News Features Treatment & Research In Psychedelics (TRIP) Program at PNI

---

Articles about Psychedelic-Assisted Therapy

PNI Experts

PNI Publishes First-Ever Paper on Psychedelics in Neurosurgery and Neuro-oncology Literature

After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).

Keith Heinzerling

What is Ketamine Therapy?

Ketamine therapy is used to treat of depression, anxiety, PTSD, end-of-life distress, chronic pain, drug/alcohol problems, and more. Learn how it works.

Amelia Garrison

Vikki’s Path to Sobriety at the Treatment & Research In Psychedelics (TRIP) Program

After years of unsuccessful therapy, Vikki transformed her life for the better with psychedelic-assisted therapy at PNI’s Pacific Treatment & Research In Psychedelics (TRIP). Learn more about her journey toward healing.

Podcasts about Psychedelic-Assisted Therapy

Anthony Effinger

31. Helping Patients and Advancing Science With a Psilocybin Trial | Karina Sergi, MS, MFT

In this episode we chat with Karina Sergi, a licensed therapist, trained the old-fashioned way, who has been exploring a new tool proven to help people who are struggling with persistent depression, addiction, and post-traumatic stress disorder: magic mushrooms.

Anthony Effinger

Magic Mushrooms: Pushing Frontiers in Mental Health Dr. Keith Heinzerling & Dr. Daniel Kelly On “Your Daily Dose with Kym Douglas”

This episode comes from the Saint John’s Health Center Foundation’s podcast, Your Daily Dose with Kym Douglas. Pacific Neuroscience Institute experts, Dr. Keith Heinzerling and Dr. Daniel Kelly discuss the Treatment & Research in Psychedelics (TRIP) program at PNI. Dr. Heinzerling, an addiction medicine specialist and TRIP director, and Dr. Kelly, director and one of the four founders of PNI describe how psychedelic-assisted therapy with compounds such as psilocybin from “magic mushrooms” in clinical trials can help treat conditions such as alcohol use disorder, anxiety, and depression. Listen to this episode to learn how these doctors envision psychedelic-assisted therapy transforming the current model of mental health care.

Anthony Effinger

The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg

Addiction and depression are two of the most widespread conditions in all of medicine. After decades of research, doctors are still looking for alternatives for when medication and cognitive training don’t work, which is all too often.

Is TRIP right for you?

For more information about treatment and research studies at the TRIP program please contact Dr. Heinzerling.

Virtual Video Visits Are Available
Our specialists have consultation openings for new patients anywhere in California.

Treatment with Ketamine: 310-582-7612
Clinical Trials: 310-582-7611

Find Out More